Semaglutide cuts BMI by 19% in treatment-resistant young adults with severe obesity, finds trial
A weekly dose of semaglutide (2.4 mg) leads to a clinically significant reduction in body mass index (BMI) and related health outcomes in young adults with severe obesity who are treatment resistant following hospital-based ...
May 14, 2026
0
3









